Analysis of expression for HsAIRK and PLK family genes, that regulate chromosome segregation in mitosis, in tumors
Analysis of expression for HsAIRK and PLK family genes, that regulate chromosome segregation in mitosis, in tumors
批准号:
14571188
负责人:
OSADA Shinji
金额:
$2.05万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2005
中文摘要
Aurora家族在M期高度表达,并被认为调节着中心体功能、染色体分离和细胞质分裂。此外,PLK家族还密切参与有丝分裂过程中的纺锤体形成和染色体分离。本研究的目的是确定与正常结肠粘膜相比,PLK或Aurora家族在原发性结直肠癌标本中是否过表达,并评估其与其他激酶的关系,作为一种潜在的新肿瘤标志物。在本研究中,我们对78例原发性结直肠癌和15例正常结直肠癌标本进行了PLK1表达的免疫组织化学分析。此外,我们还检测了其他激酶,Aurora-A和Aurora-C与PLK1表达的关系。在15例正常结肠黏膜中,13例隐窝细胞PLK1呈弱阳性染色。57例(73.1%)结直肠癌患者PLK1表达升高,与pT、pN及Dukes分级有显著相关性。PLK1高表达和低表达病变值分别为54.7±10.3% (mean±SD)和45.9±11.9%。PLK1与Aurora-A有显著相关性,但与Aurora-A或aurora - c - 2相比,PLK1的染色更为弥漫性和广泛性。本研究对78例原发性结直肠癌、36例结直肠腺瘤和15例正常结直肠标本中HsAIRK1和HsAIRK3的表达进行了免疫组化分析。在53例(67.9%)结直肠癌患者中观察到HsAIRK1表达升高,在40例(51.3%)结直肠癌患者中观察到HsAIRK3表达升高。结直肠腺瘤中分别有11例(30.6%)和7例(19.4%)高表达HsAIRK1和HsAIRK3,介于结直肠癌和正常结直肠粘膜之间。有趣的是,在结直肠癌中,HsAIRK1过表达与p53积累显著相关。我们的研究结果表明,PLK1或Aurora A的过表达可能具有致病、预后和增殖的重要性,因此这些有丝分裂相关基因可能有潜力作为结直肠癌的新肿瘤标志物。少
英文摘要
Aurora family are highly expressed during M phase, and have been suggested to regulate centrosome function, chromosome segregation, and cytokinesis. In addition, PLK family is also intimately involved in spindle formation and chromosome segregation during mitosis. The purpose of this study was to determine whether PLK or Aurora family are overexpressed in primary colorectal cancer specimens as compared with normal colon mucosa and assess its relation to other kinases as a potential new tumor marker.1.PLKIn the present study, immunohistochemical analyses were performed of PLK1 expression in 78 primary colorectal cancers as well as 15 normal colorectal specimens. Furthermore, we examined the relationship between other kinases, Aurora-A and Aurora-C, and PLK1 expression. In normal colon mucosa, some crypt cells showed weak positive staining for PLK1 in 13 out of 15 cases. Elevated expression of PLK1 was observed in 57 (73.1%) of the colorectal cancers, statistically significant associatio … More ns being evident with pT, pN and the Dukes' classification. Values for lesions with high and low PLK1 expression were 54.7±10.3% (mean±SD) and 45.9±11.9%. PLK1 was significantly associated with Aurora-A, but PLK1 staining was more diffuse and extensive than for Aurora-A or Aurora-C.2.AuroraIn the present study, immunohistochemical analyses were performed of HsAIRK1 and HsAIRK3 expression in 78 primary colorectal cancers and 36 colorectal adenomas as well as 15 normal colorectal specimens. Elevated expression of HsAIRK1 was observed in 53 (67.9%) of the colorectal cancers, and of HsAIRK3 in 40 (51.3%). Furthermore, colorectal adenomas showed high expression of HsAIRK1 and HsAIRK3 in 11 (30.6%) and 7 (19.4%) cases, respectively, thus being intermediate between colorectal cancers and normal colorectal mucosa. Interestingly, HsAIRK1 overexpression was significantly associated with p53 accumulation in colorectal cancers.Our results suggest overexpression of PLK1 or Aurora A might be of pathogenic, prognostic and proliferative importance, so that these mitosis-related genes might have potential as a new tumor marker for colorectal cancers. Less
期刊论文(22)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
加藤 浩樹: "ヒト大腸癌における細胞周期関連遺伝子polo-like kinase (PLK1)及びPLK3の発現に関する検討"外科系連合学会誌. 28巻・1号. (2003)
加藤弘树:“人类结直肠癌中细胞周期相关基因 polo 样激酶 (PLK1) 和 PLK3 的表达”,日本外科学会杂志,第 28 卷,第 1 期(2003 年)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
ヒト大腸癌における細胞周期関連遺伝子Polo-like kinase(Plk)1およびPlk3の発見に関する検討
人结直肠癌细胞周期相关基因Polo样激酶(Plk)1和Plk3的发现研究
DOI:
--
发表时间:
2003
期刊:
日本外科系連合学会誌 28
影响因子:
--
作者:
[加藤浩樹, 高橋孝夫, 杉山保幸, 國枝克行, 佐治重豊]
通讯作者:
佐治重豊
高橋 孝夫: "Polo-like kinase1 (PLK1) is Overexpressed in Primary Colovectal Cancers"Japanese journal of Cancer Research. (in press).
Takao Takahashi:“Polo 样激酶 1 (PLK1) 在原发性结肠直肠癌中过度表达”,日本癌症研究杂志(正在出版)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
DOI:
10.1002/jso.20006
发表时间:
2004-01-01
期刊:
JOURNAL OF SURGICAL ONCOLOGY
影响因子:
2.5
作者:
[Osada, S, Saji, S, Kuno, T]
通讯作者:
Kuno, T
Clinical significance of combination study of apoptotic factors and proliferating cell nuclear antigen in estimating the prognosis of hepatocelluar carcinoma
凋亡因子与增殖细胞核抗原联合研究评估肝细胞癌预后的临床意义
DOI:
--
发表时间:
2004
期刊:
Journal of surgical Oncology 85
影响因子:
--
作者:
[Osada S, Saji S, Kuno T]
通讯作者:
Kuno T
共 10 条
Cryo-therapy was indicated to induce tumor growth inhibition and immune reation
-
批准号:23591985
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.24万
-
财政年份:2011
-
负责人:OSADA Shinji
-
依托单位:
国内基金
海外基金
登录
查看更多内容
CRISPR筛选发现PLK1调控子宫内膜癌进展的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:芦晓晶
-
依托单位:
千金藤素通过靶向PLK1激活STING/CXCL10重塑肿瘤微环境增效PD-1抑制剂抗非小细胞肺癌机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:江泽波
-
依托单位:
脂肪干细胞高表达PLK1促进糖尿病创面中缺氧内皮祖细胞自噬的机制研究
-
批准号:2024Y9037
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:徐娜婷
-
依托单位:
PLK1磷酸化ELF1招募Set1/COMPASS复合体调控胶质瘤谷氨酰胺代谢的机制研究
-
批准号:
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:杨睿
-
依托单位:
硒-磷纳米薄片调控PLK1信号通路介导细胞周期抑制高效增敏肝癌放疗
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:陈樑
-
依托单位:
靶向PLK1通过铁死亡途径逆转BRAFV600E结直肠癌对BRAF和EGFR抑制剂耐药的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:30.0万元
-
批准年份:2024
-
负责人:潘京华
-
依托单位:
m6A介导的PLK1翻译促进卵巢癌染色体不稳定驱动淋巴结转移前
微环境形成的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:孙睿
-
依托单位:
FOXM1/PLK1共表达介导细胞自噬在胃癌中的作用及分子机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:顾倩
-
依托单位:
PLK1联合IFI16预测肠白塞综合征患者疾病活动及预后的队列研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:5.0万元
-
批准年份:2024
-
负责人:鲍华芳
-
依托单位:
PLK1调控JNK介导的细胞凋亡通路在胰腺导管腺癌MEK抑制剂治疗耐药中的作用及分子机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位: